Friedman A 1

1. BNT162b2 vaccine induces potent SARS-CoV-2 neutralising immunoglobulins in lung mucosa
2. Antibody response in elderly vaccinated four times with an mRNA anti-COVID-19 vaccine
3. Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgA
1